CellaVision
214 SEK +3,38 %1.470 investorer følger denne virksomhed
CellaVision is active in medical technology. The company's operations develop and market image analysis systems for diagnosing blood and other body fluids. The products are intended to replace traditional microscope analysis. Operations are conducted on a global level, primarily in the Nordic countries, Europe and North America, where customers consist of research institutes. The head office is located in Lund.
Omsætning
639,34 mio.
EBIT %
24,76 %
P/E
43,15
Udbytteafkast, %
0,93 %
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
CEVI
Daglig lav / høj pris
206,5 / 216,5
SEK
Markedsværdi
5,1 mia. SEK
Aktieomsætning
2,92 mio. SEK
Volumen
14 t
Seneste videoer
Finanskalender
Delårsrapport
20.07.2023
Delårsrapport
25.10.2023
Årsrapport
07.02.2024
Viser Alle indholdstyper
